This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: The Innovations of Keith Lorimer
Introduction
Keith Lorimer is an accomplished inventor based in Great Britain. He has made significant contributions to the field of pharmaceuticals, particularly through his work on genistein and its crystalline forms. His innovative approach has the potential to impact therapeutic treatments, especially in cancer care.
Latest Patents
Keith Lorimer holds a patent related to "Crystalline Forms Of Genistein." This patent discloses new crystalline forms of genistein, including various salts such as sodium, potassium, calcium, magnesium, and others. The patent also describes therapeutic compositions that contain these crystalline forms and methods for treating cancer by administering these compounds to patients in need.
Career Highlights
Lorimer is associated with Axcentua Pharmaceuticals AB, where he has been instrumental in advancing research and development in pharmaceutical formulations. His work focuses on the therapeutic applications of genistein, showcasing his commitment to improving patient outcomes through innovative solutions.
Collaborations
He has collaborated with notable colleagues, including Anders Berkenstam and Stefan Rehnmark, to further enhance the research and development efforts at Axcentua Pharmaceuticals AB.
Conclusion
Keith Lorimer's contributions to the field of pharmaceuticals, particularly through his work on genistein, highlight his innovative spirit and dedication to advancing medical science. His research has the potential to lead to significant advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile